Lotte Biologics has completed construction of its first biopharmaceutical production facility within the Songdo Biocampus in Incheon, South Korea. The newly built factory is located in the Songdo International City district. The company has now submitted an application for usage approval to begin operations. This marks a significant step in Lotte Biologics’ expansion of its biopharmaceutical manufacturing capabilities. The facility is expected to contribute to the growth of the biopharmaceutical industry in the region. Further details regarding the facility’s production capacity and specific products were not immediately available. The completion of this first factory paves the way for future development within the Songdo Biocampus.